Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Acquisitions (2021 - 2022)

PAVmed has reported Acquisitions over the past 2 years, most recently at $1.0 million for Q3 2022.

  • Quarterly results put Acquisitions at $1.0 million for Q3 2022, up 900.0% from a year ago — trailing twelve months through Dec 2022 was $3.2 million (changed N/A YoY), and the annual figure for FY2022 was $3.2 million, up 42.41%.
  • Acquisitions for Q3 2022 was $1.0 million at PAVmed, down from $2.1 million in the prior quarter.
  • Over the last five years, Acquisitions for PAVM hit a ceiling of $2.1 million in Q4 2021 and a floor of $100000.0 in Q3 2021.